- Home
- JRS vs PROF Comparison
JRS vs PROF Comparison
Compare JRS & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | JRS | PROF |
|---|---|---|
| Founded | 2001 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 223.9M | 230.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | JRS | PROF |
|---|---|---|
| Price | $7.70 | $8.07 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | 86.6K | ★ 232.3K |
| Earning Date | 01-01-0001 | 03-05-2026 |
| Dividend Yield | ★ 8.87% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $14,297,000.00 |
| Revenue This Year | N/A | $64.23 |
| Revenue Next Year | N/A | $113.06 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 67.94 |
| 52 Week Low | $5.95 | $3.76 |
| 52 Week High | $8.00 | $8.95 |
Technical Indicators
Market Signals| Indicator | JRS | PROF |
|---|---|---|
| Relative Strength Index (RSI) | 51.45 | 54.56 |
| Support Level | $7.71 | $7.59 |
| Resistance Level | $7.84 | $8.26 |
| Average True Range (ATR) | 0.10 | 0.60 |
| MACD | 0.02 | -0.07 |
| Stochastic Oscillator | 54.17 | 45.85 |
Price Performance
Historical ComparisonAbout JRS Nuveen Real Estate Income Fund of Beneficial Interest
Nuveen Real Estate Income Fund is a diversified closed-end investment company. The Fund invests in income-producing common stocks, preferred stocks, convertible preferred stocks, and debt securities issued by real estate companies.
About PROF Profound Medical Corp.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.